Ethnobotany & the process of drug discovery: A laboratory exercise

American Biology Teacher

Volumn 71, Issue 9, 2009, Pages 541-547

  Shelley, Brian C L ^a  

^a Saint Josepj's College of Maine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72949091202     PISSN: 00027685     EISSN: None     Source Type: Journal    
DOI: 10.1662/005.071.0908     Document Type: Article

References (46)

1. Abbott, W.S. (1925). A method of computing the effectiveness of insecticides. Journal of Economic Entomology, 18, 265-267.
2. Alexiades, M.N.&Sheldon J.W. (Eds.) (1996). SelectedGuidelinesforEthnobotanical Research: A Field Manual. Bronx, NY: The New York Botanical Garden.
3. Anderson, J.E., Goetz, C.M., McLaughlin, J.L & Suffness, M. (1991). A blind comparison of simple bench-top bioassays and human tumour cell cytotoxicities as antitumor prescreens. Phytochemical Analysis, 2, 107-111.
4. Baker, J.T., Borris, R.P., Carte, B., Cordell, G.A., Soearto, D.D. & Cragg, G.M. (1995). Natural product drug discovery and development: New perspectives on international collaboration. Journal of Natural Products, 58, 1325-1357.
5. Balick, M.J. (1990). Ethnobotany and the identification of therapeutic agents from the rainforest. In D.J. Chadwick &J. Marsh (Eds.), Bioadive Compounds from Plants (pp. 22-39). Chichester, U.K.: John Wiley & Sons.
6. Bauer, A.W., Kirby, W.M.M., Sherris, J.C. & Turck, M. (1966). Antibiotic susceptibility testing by a standardized single disk method. American Journal Clinical Pathology, 45, 493-496.
7. Bramwell, D. (2002). How many plant species are there? Plant Talk, 28, 32.
8. Butler, M.S. (2004). The role of natural product chemistry in drug discovery. Journa/ of Natural Products, 67, 2141-2153.
9. Cragg, G.M. & Newman, D.J. (2005). Plants as a source of anti-cancer agents. Journa/ of Ethnopharmacology, 100, 72-79.
10. Cordell, G.A.&Colvard,M.D. (2005). Some thoughts on the future of ethnopharmacology. Journal of Ethnopharmacology, 100, 5-14.
11. Dhingra, V., K.V. Rao, K.V. & Narasu, M.L. (2000). Current status of artemisinin and its derivatives as antimalarial drugs. Life Sciences, 66, 279-300.
12. Duke, J. (2006). Dr. Duke's Phytochemical and Ethnobotanical Databases. . http://www.ars-grin.gov/duke/
13. Einhellig, F.A., G.R. Leather, G.R. & Hobbs, L.I. (1985). Use of Lemna minor L. as a bioassay on a\\e\opathy. Journal of Chemical Ecology, 11, 65-72.
14. Fabricant, D.S. & Farnsworth, N.R. (2001). The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives, 109, 69-75.
15. Farnsworth, N.L, Akerele, O., Bingel, A.S., Soejarto, D.D. & Guo, Z.G. (1985). Medicinal plants in therapy. Bulletin of World Health Organization, 63, 965-981.
16. Ferrigni, N.R., Putnam, J.E., Anderson, B., Jacobsen, L.B., Nichols, D.E., Moore, D.S., McLaughlin, J.L, Powell, R.C. & Smith Jr., C.R. (1982). Modification and evaluation of the potato disc assay and antitumor screening of Euphorbiaceae seeds. Journal of Natural Products, 45, 679-686.
17. Foster, S. & Duke, J. (2000). A Field Guide to Medicinal Plants and Herbs, 2nd Edition. Boston, MA: Houghton Mifflin Company.
18. Galsky, A.G., Kozimor, R., Piotrowski, D. & Powell, R.G. (1981). The crown-gall potato disk bioassay as a primary screen for compounts with antitumor activity. Journal of the National Cancer Institute, 67, 689-692.
19. Grifo, F., Newman, D., Fairfield, A.S., Bhattacharya, B, &Grupenhoff,J.T. (1997). The origins of prescription drugs. In F. Grifo & J. Rosenthal (Eds.), Biodiversity and Human Health (pp. 131-163). Washington, DC: Island Press.
20. Harvey, A. (2000). Strategies for discovering drugs from previously unexplored natural products. Drug Discovery Today, 5, 294-300.
21. Hien, T.T. & White, N.J. (1993). Qinghaosu. Lancet, 341, 603-608.
22. Koehn, F.E. & Carter, G.T. (2005). The evolving role of natural products in drug discovery. Nature Reviews: Drug Discovery, 4, 206-220.
23. Klayman, D.L. (1985). (Quinghaosu artemisinin): An antimalarial drug from China. Science, 228, 1049-1055.
24. Kyerematen, G.A. & Ogunlana, E.O. (1987). An integrated approach to the pharmacological evaluation of traditional materia medica. Journal of Ethnopharmacology, 20, 191-207.
25. Lai, H. & Singh, N.P. (1995). Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransterrin. Cancer Letters, 91, 41-46.
26. Lai, H. & Singh, N.P. (2006). Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Letters, 231, 43-48.
27. Lawton, J.H. & May, R.M. (1995). Extinction Rates. Oxford, U.K.: Oxford University Press.
28. Lewis, W.H. & Elwin-Lewis, M.P. (1995). Medicinal plants as sources of new therapeutics. Annuals Missouri Botanical Garden, 82, 16-24.
29. Mann, J. (2002). Natural products in cancer chemotherapy: past, present and future. Nature Reviews Cancer, 2, 143-148.
30. Martin, G.J. (1995). Ethnobotany: A Methods Manual. New York, NY: Chapman & Hall.
31. Meyer, B.N., Ferrigni, N.R., Putnam, J.E., Jacobsen, L.B., Nichols, D.E. & McLaughlin, J.L. (1982). Brine shrimp: A convenient general bioassay for active plant constituents. Planta Medica, 45, 31-34.
32. McCloud, T.G. (2002). Personal communication. SAIC Frederick, NCI-Frederick Cancer Research and Development Center, 3 January, 2002.
33. McLaughlin, J.L, Chang, C. & Smith, D.L. (1993). Simple bench-top bioassays (brine shrimp and potato discs) for the discovery of plant antitumor compounds. In A.D. Kinghorn & M.F. Balandrin (Eds.), Human Medicinal Agents from Plants (pp. 112-137). American Chemical Society Symposium Series 534, American Chemical Society.
34. Missouri Botanical Garden. (1995-2005). Rare Books. Available online at: http:// www.illustratedgarden.org.
35. Moerman, D. (2006). Native American Ethnobotany. A database of foods, drugs, dyes, and fibers of Native American peoples derived from plants." University of Michigan-Dearborn, .
36. Newman, D.J., Cragg, G.M. & Snader, K.M. (2003). Natural products as sources of new drugs over the period 1981-2002. Journal of Natural Products, 66,1022-1037.
37. Pimm, S.L, Russell, G.J., Gittleman, J.L. & Brooks, T.M. (1995). The future of biodiversity. Science, 269, 347-350.
38. Primack, R.B. (2002). Essentials of Conservation Biology. Sunderland, MA: Sinauer Associates, Inc.
39. Singh, N.P. & Lai, H. (2001). Selective toxicity of dihydroartemisinin and holotransterrin toward human breast cancer cells. Life Sciences, 70, 49-56.
40. Strohl, W.R. (2000). The role of natural products in a modern drug discovery program. Drug Discovery Today, 5, 39-41.
41. Tagboto, S. & Townson, S. (2001). Antiparasitic properties of medicinal plants and other naturally occurring products. Advances in Parasitology, 50, 199-295.
42. Trotter II, R.T., Logan, M.H., Rocha, J.M. & Boneta, J.L. (1983). Ethnography and bioassay: combined methods for a preliminary screen of home remedies for potential pharmacological activity. Journa/ of Ethnopharmaco/oly, 8, 113-119.
43. Tulp, M. & Bohlin, L. (2002). Functional versus chemical diversity: is biodiversity important for drug discovery? TRENDS in Pharmacological Sciences, 23, 225-231.
44. Verpoorte, R. (1998). Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discovery Today, 3, 232-238.
45. Vuorela, P., Leinonen, M., Saikku, P.,Tammela, P, Rauha,J.-P, Wennberg,T.&Vuorela, H. (2004). Natural products in the process of finding new drug candidates. Current Medicinal Chemistry, 11, 1375-1389.
46. Wilson, E.O. (1992). The Diversity of Life. Cambridge, MA: Harvard University Press.